Icon

DOXIL (LIPOSOMAL) (nda050718)- (20MG/10ML (2MG/ML),50MG/25ML (2MG/ML))

DOXORUBICIN HYDROCHLORIDE BAXTER HLTHCARE CORP
20MG/10ML (2MG/ML),50MG/25ML (2MG/ML)
No No
2009-Oct-20 Expired
2014-May-17 None
None No
DOXIL is an anthracycline topoisomerase inhibitor indicated for:  Ovarian cancer: After failure of platinum-based chemotherapy.  AIDS-related Kaposi’s Sarcoma: After failure of prior systemic. chemotherapy or intolerance to such therapy.  Multiple Myeloma: In combination with bortezomib in patients who have not previously received bortezomib and have received at least one prior therapy.
6 0 5
Total Other Developers None
Drugs with Suitability No
20MG/10ML (2MG/ML) ** ** - - -
50MG/25ML (2MG/ML) ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 4
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** *** ***** *** ************** ********** ******* *********** *****-****** *******, *****, ******* ******, ***** (***) ***
****** ***** ****** *** ******** ********* ******* *********** ***** ******* ******* ****** (***), *****, *******, ****** (***) ***
****** ** ****** ***** ****** ******* *********** ****** ********, ******, **********, ********* *** ***, ***** (***) ***
****** ***** ************ ***** ************ ******* *********** **** **. **, ******* ******* ******** ****, ******* - ***** *. *. **. **, ******, *** : ******, *********, ******* ******, ***** (***) ***
****** ***** ****** ****** *********** *********** ** ********* ********** **, **** *******, *** ****** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.